uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Lung cancer among native and foreign-born Swedes: histopathology, treatment, and survival
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Centre for Research and Development, Gävleborg. Gavle Cent Hosp, Dept Resp Med, S-80187 Gavle, Sweden.;Karolinska Inst, Stockholm, Sweden..
Karolinska Univ Hosp, Dept Resp Med & Allergy, Stockholm, Sweden..
Karolinska Univ Hosp, Dept Resp Med & Allergy, Stockholm, Sweden..
Univ Gavle, Fac Hlth & Occupat Studies, Dept Hlth & Caring Sci, Gavle, Sweden..
Show others and affiliations
2016 (English)In: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 55, no 11, 1344-1348 p.Article in journal (Refereed) Published
Abstract [en]

Background: Lung cancer (LC) is the leading cause of cancer-related death worldwide, including Sweden. Several studies have shown that socioeconomic status affects the risk, treatment, and survival of LC. Due to immigration after Second World War, foreign-born people constitute 12.5% of the Swedish population. We wanted to investigate if there were any differences in LC management, treatment and survival among the foreign-born Swedes (FBS) compared to the native Swedish population (NatS) in Stockholm.Material and methods: A retrospective analysis of all patients diagnosed with non-small cell lung cancer (NSCLC) at the Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Solna from 1 January 2003 to 31 December 2008 was made. In all, 2041 cases of LC were diagnosed, thereof 1803 with NSCLC. Of these, 211 (11.7%) were FBS.Results: The mean age of NatS and FBS patients was 69.9 years, median 70 (range 26-96) and 66.0 years, median 66 (range 38-94), respectively (p<0.001). In all, 89.8% of NatS and 90.0% of FBS were either smokers or former smokers. Adenocarcinoma was the most common subtype in both groups (NatS 54.7%, FBS 48.3%). In 140 (8.8%) of the NatS and 17 (8.1%) of the FBS the diagnosis was clinical only. There were no significant differences in stage at diagnosis, nor in performance status (PS) or different therapies between the groups. The median overall survival time for the NatS was 272 days and for FBS 328 days, again no significant difference. However, the median overall survival time for female NatS was 318 days and for female FBS 681 days (p=0.002).Conclusion: FBS patients were significantly younger than NatS at diagnosis, and female FBS lived longer than female NatS, but otherwise there were no significant differences between NatS and FBS patients with LC regarding diagnosis, treatment, and survival.

Place, publisher, year, edition, pages
2016. Vol. 55, no 11, 1344-1348 p.
National Category
Cancer and Oncology
URN: urn:nbn:se:uu:diva-308804DOI: 10.1080/0284186X.2016.1189095ISI: 000386374500014PubMedID: 27556916OAI: oai:DiVA.org:uu-308804DiVA: diva2:1051239
Available from: 2016-12-01 Created: 2016-11-30 Last updated: 2016-12-01Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Koyi, HirshBrandén, Eva
By organisation
Centre for Research and Development, Gävleborg
In the same journal
Acta Oncologica
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 31 hits
ReferencesLink to record
Permanent link

Direct link